Apr 4, 2017
InfoBionic Names Industry Veteran Stuart Long Chief Executive Officer
Mar 6, 2017
Herantis Pharma’s clinical study with Lymfactin advances to high dose level
Feb 13, 2017
miRagen Therapeutics Completes merger with Signal Genetics and Concurrent $40.7M Equity Financing
Feb 7, 2017
Nido Surgical Raises $1.3M Series A Led By Broadview Ventures
Jan 16, 2017
Remedy Granted Orphan Drug Designation
Oct 31, 2016
miRagen Therapeutics & Signal Genetics Sign Merger Agreement
